Detection of late gadolinium enhancement in patients with hypertrophic cardiomyopathy using machine learning

Keitaro Akita1, Kenichiro Suwa2, Kazuto Ohno2

  • 1Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA; Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

PubMed

Insights

Machine learning models can predict late gadolinium enhancement (LGE) in hypertrophic cardiomyopathy (HCM) using clinical data, potentially reducing the need for cardiac magnetic resonance (CMR) imaging. This approach aids physicians in identifying patients likely to have LGE.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) indicates myocardial fibrosis in hypertrophic cardiomyopathy (HCM), a risk factor for fatal arrhythmias.
  • CMR is resource-intensive and sometimes contraindicated, necessitating alternative diagnostic methods.

Purpose of the Study:

  • To develop and validate a machine learning (ML) algorithm for detecting LGE in HCM patients using clinical parameters.
  • To assess the utility of ML in identifying HCM patients with a high pre-test probability of LGE.

Main Methods:

  • A ridge classification ML model was trained on 22 clinical parameters (including echocardiographic data) from 554 HCM patients in the US.
  • The model was validated on a separate cohort of 188 HCM patients from Japan.
  • Performance was evaluated using the area under the receiver-operating-characteristic curve (AUC).

Main Results:

  • The ML model achieved an AUC of 0.77 in the test set (95% CI 0.70-0.84).
  • The ML model significantly outperformed a reference model based on 3 conventional risk factors (AUC 0.69, P=0.01).
  • LGE was present in 54% of the training set and 40% of the test set.

Conclusions:

  • ML analysis of clinical parameters can effectively distinguish the presence of LGE on CMR in HCM patients.
  • This ML model can assist physicians in identifying HCM patients who would benefit most from CMR.
  • The findings support the use of ML as a tool to optimize CMR utility in HCM management.
Abstract